Interim Chief Innovation Officer | Precision Medicine & Molecular Diagnostics
Midlands UK | Significant On-Site Presence Required
Executive Leadership | Transformation | Innovation Strategy
An opportunity to lead the next phase of innovation within a growing molecular diagnostics business.
KEMIO Consulting is partnering with an established and ambitious UK-based molecular diagnostics company experiencing strong commercial momentum and increasing demand for its innovative diagnostic technologies.
We are seeking an experienced Interim Chief Innovation Officer (CIO) to lead a critical transformation of the organisation’s innovation function, strengthen its scientific and technical capabilities, and establish a clear strategy for future growth.
The business has an established portfolio of cancer diagnostics technologies and significant ambitions to advance non-invasive, based testing and multi-cancer early detection.
This is a hands-on executive leadership appointment, requiring someone who can combine scientific credibility, strategic vision and the ability to deliver meaningful organisational change.
The Opportunity
Reporting directly to the CEO and operating as part of the Executive Leadership Team, you will take ownership of three critical priorities:
What We’re Looking For
We are particularly interested in senior executives who can demonstrate:
Significant leadership experience within Molecular Diagnostics, Genomics, IVD, Precision Medicine or related Life Sciences sectors.
A track record of successfully transforming or scaling R&D, product development or innovation functions.
Experience progressing diagnostic technologies through development, validation, regulatory readiness and commercialisation.
Strong understanding of bioinformatics, computational biology and associated technical infrastructure.
Proven ability to evaluate scientific portfolios, allocate resources and make difficult strategic decisions.
Experience converting scientific innovation, intellectual property and technology into tangible commercial and patient outcomes.
Strong executive leadership, stakeholder management and organisational change capabilities.
The First 90 Days
This is a delivery-focused assignment with clear expectations:
Why Consider This Opportunity?
This is an opportunity to make a significant and measurable impact within a business operating at the forefront of molecular diagnostics and cancer detection.
You will have the authority to influence scientific direction, reshape technical capabilities and establish an innovation strategy that supports both patient outcomes and long-term commercial growth.
Contact KEMIO Consulting or message me directly to learn more about this opportunity and have a confidential discussion/
#InterimCIO #ChiefInnovationOfficer #MolecularDiagnostics #PrecisionMedicine #Genomics #CancerDiagnostics #ExecutiveSearch #InterimLeadership #LifeSciences #Bioinformatics #KEMIOConsulting
Posted 21 Oct 2026